Latest News

Complimentary Webinar: Optimizing the Use of Clinical Trial Disclosure Systems

MMS is collaborating with the DIA for an upcoming complimentary webinar, “Optimizing the Use of Clinical Trial Disclosure Systems to Meet Complex and Evolving Global Regulatory Requirements.”

Learning Objectives

  • Determine key drivers for the use of technology to manage clinical trial disclosures processes
  • Implement efficiencies and consistencies gained from enabling reuse of protocol and results summary content across regions
  • Understand the importance of integrating drug and submission-level metrics into disclosures systems
  • Identify system features and functionality that are key to achieving global compliance
  • Recognize the importance of automated workflow management to manage the disclosures life cycle

Presenters

  • Kasim McLain, Manager, Disclosure Services, MMS
  • Peggy Zorn, MS, MBA, Associate Director, Regulatory Affairs, Submissions and Transparency, MMS
  • Gitta Irmer, MS, Associate Director, Data Quality and Standards, Eisai
  • Zach Weingarden, MS, Product Solutions Manager, TrialAssure

View the webinar by clicking here!

Suggested For You

news

September 26th, 2017

Pfizer Selects MMS as Preferred Provider for Plain Language Summary Writing Support

regulatory intelligence

August 9th, 2024

FDA Updates 2024 Language Access Plan

perspectives

May 29th, 2024

Confined Deferrals in Clinical Trial Applications: Anticipating the Revised EU CTR Transparency Rules